These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35348331)

  • 21. Cancer cell membrane-coated C-TiO
    Ning S; Dai X; Tang W; Guo Q; Lyu M; Zhu D; Zhang W; Qian H; Yao X; Wang X
    Acta Biomater; 2022 Oct; 152():562-574. PubMed ID: 36067874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hybrid theranostic microbubbles for ultrasound/photoacoustic imaging guided starvation/low-temperature photothermal/hypoxia-activated synergistic cancer therapy.
    Tian F; Zhong X; Zhao J; Gu Y; Fan Y; Shi F; Zhang Y; Tan Y; Chen W; Yi C; Yang M
    J Mater Chem B; 2021 Nov; 9(45):9358-9369. PubMed ID: 34726226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An efficient delivery of photosensitizers and hypoxic prodrugs for a tumor combination therapy by membrane camouflage nanoparticles.
    Wang H; Zhang C; Zhang Y; Tian R; Cheng G; Pan H; Cui M; Chang J
    J Mater Chem B; 2020 Apr; 8(14):2876-2886. PubMed ID: 32191252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polydopamine-coated UiO-66 nanoparticles loaded with perfluorotributylamine/tirapazamine for hypoxia-activated osteosarcoma therapy.
    Chen H; Fu Y; Feng K; Zhou Y; Wang X; Huang H; Chen Y; Wang W; Xu Y; Tian H; Mao Y; Wang J; Zhang Z
    J Nanobiotechnology; 2021 Sep; 19(1):298. PubMed ID: 34592996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-LDLR modified TPZ@Ce6-PEG complexes for tumor hypoxia-targeting chemo-/radio-/photodynamic/photothermal therapy.
    Song C; Xu W; Wei Z; Ou C; Wu J; Tong J; Cai Y; Dong X; Han W
    J Mater Chem B; 2020 Jan; 8(4):648-654. PubMed ID: 31898718
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pH-Responsive Charge-Convertible Drug Delivery Nanocarrier for Precise Starvation and Chemo Synergistic Oncotherapy.
    Zhou Y; Gao X; Lu Y; Zhang R; Lv K; Gong J; Feng J; Zhang H
    Chempluschem; 2023 Feb; 88(2):e202200394. PubMed ID: 36725346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tirapazamine-loaded UiO-66/Cu for ultrasound-mediated promotion of chemodynamic therapy cascade hypoxia-activated anticancer therapy.
    Yang L; Wang Z; Gong H; Gai S; Shen R
    J Colloid Interface Sci; 2023 Mar; 634():495-508. PubMed ID: 36542978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Precise gliomas therapy: Hypoxia-activated prodrugs sensitized by nano-photosensitizers.
    Zhang H; Shi C; Han F; Li M; Ma H; Sui R; Long S; Sun W; Du J; Fan J; Piao H; Peng X
    Biomaterials; 2022 Oct; 289():121770. PubMed ID: 36075142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination of the bioreductive drug tirapazamine with the chemotherapeutic prodrug cyclophosphamide for P450/P450-reductase-based cancer gene therapy.
    Jounaidi Y; Waxman DJ
    Cancer Res; 2000 Jul; 60(14):3761-9. PubMed ID: 10919648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physical Dissolution Combined with Photodynamic Depletion: A Two-Pronged Nanoapproach for Deoxygenation-Driven and Hypoxia-Activated Prodrug Therapy.
    Lu J; Yu J; Xie W; Gao X; Guo Z; Jin Z; Li Y; Fahad A; Pambe NU; Che S; Wei Y; Zhao L
    ACS Appl Bio Mater; 2023 Sep; 6(9):3902-3911. PubMed ID: 37644623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biomimetic cell membrane-coated glucose/oxygen-exhausting nanoreactor for remodeling tumor microenvironment in targeted hypoxic tumor therapy.
    Guo H; Zhang W; Wang L; Shao Z; Huang X
    Biomaterials; 2022 Nov; 290():121821. PubMed ID: 36201949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bioengineered "Molecular Glue"-Mediated Tumor-Specific Cascade Nanoreactors with Self-Destruction Ability for Enhanced Precise Starvation/Chemosynergistic Tumor Therapy.
    Zhang Q; Xuan Q; Wang C; Shi C; Wang X; Ma T; Zhang W; Li H; Wang P; Chen C
    ACS Appl Mater Interfaces; 2023 Sep; 15(35):41271-41286. PubMed ID: 37622208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective potentiation of the hypoxic cytotoxicity of tirapazamine by its 1-N-oxide metabolite SR 4317.
    Siim BG; Pruijn FB; Sturman JR; Hogg A; Hay MP; Brown JM; Wilson WR
    Cancer Res; 2004 Jan; 64(2):736-42. PubMed ID: 14744792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Highly Active Nano-Reactor for Responding Tumor Microenvironment and Antitumor Therapy.
    Zhang S; Liu Y; Liu B
    Technol Cancer Res Treat; 2022; 21():15330338221095670. PubMed ID: 35712964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Iodinated cyanine dye-based nanosystem for synergistic phototherapy and hypoxia-activated bioreductive therapy.
    Dong Y; Zhou L; Shen Z; Ma Q; Zhao Y; Sun Y; Cao J
    Drug Deliv; 2022 Dec; 29(1):238-253. PubMed ID: 35001784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Zwitterionic Block Copolymer Prodrug Micelles for pH Responsive Drug Delivery and Hypoxia-Specific Chemotherapy.
    Zhao J; Peng YY; Diaz-Dussan D; White J; Duan W; Kong L; Narain R; Hao X
    Mol Pharm; 2022 Jun; 19(6):1766-1777. PubMed ID: 34473523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Introducing urea into tirapazamine derivatives to enhance anticancer therapy.
    Xu Y; Lv J; Kong C; Liu Y; Wang K; Tang Z; Chen X
    Natl Sci Rev; 2024 Apr; 11(4):nwae038. PubMed ID: 38440219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of hypoxia-induced mRNA expressions of HIF-1alpha and osteopontin and in vitro radiosensitization by tirapazamine in human nasopharyngeal carcinoma HNE-1 and CNE-1 cells.
    Xu P; Huang JM; Ren Y; Zha X; Deng BF; Wu JH; Lang JY
    Chin J Cancer; 2010 Feb; 29(2):126-30. PubMed ID: 20109337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Near-infrared light triggered liposomes combining photodynamic and chemotherapy for synergistic breast tumor therapy.
    Yang Y; Yang X; Li H; Li C; Ding H; Zhang M; Guo Y; Sun M
    Colloids Surf B Biointerfaces; 2019 Jan; 173():564-570. PubMed ID: 30347383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improving Tirapazamine (TPZ) to Target and Eradicate Hypoxia Tumors by Gold Nanoparticle Carriers.
    Ajnai G; Cheng CC; Kan TC; Lu JW; Rahayu S; Chiu A; Chang J
    Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.